-transparent.png){kind=logo}
Patients with unstable angina pectoris have increased thrombocyte aggregation and disturbances in serum prostaglandin balance. As a pilot project, we conducted a single-blind investigation of 24 patients with unstable angina pectoris treated with dilthiazem (n = 12, 240-360 mg) or verapamil (n = 12, 240-360 mg) for ten days. At the commencement of the investigation, both patient groups had hyperaggregating thrombocytes and increased serum-thromboxan-B2 (TXB2) as compared to healthy individuals (p < 0.01). In the patient group treated with dilthiazem, the aggregation threshold rose (p < 0.01), and the serum TXB2 values fell to approximately normal (p < 0.05). In the patient group treated with verapamil, no significant changes were observed in the measurements registered. The difference between the two groups remained significant during the entire therapeutic period (p < 0.01). Thus, dilthiazem appears to counteract thrombocyte aggregation in patients with unstable angina pectoris.
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
July 1988,
Deutsche medizinische Wochenschrift (1946),
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
April 1988,
Clinical pharmacology and therapeutics,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
August 1998,
Zeitschrift fur Kardiologie,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
January 1986,
International journal of clinical pharmacology research,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
January 2004,
Klinicheskaia meditsina,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
January 1989,
Zeitschrift fur Kardiologie,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
June 1982,
Annales de cardiologie et d'angeiologie,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
January 2001,
Klinicheskaia meditsina,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
December 1981,
Circulation,
F Lyck, and
L Holmvang, and
A M Grauholt, and
P Grande
December 1990,
Ugeskrift for laeger,
